特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

スコポラミンの世界市場:産業分析、市場規模、シェア、成長、動向、予測

Global Scopolamine Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

発行 Value Market Research 商品コード 809149
出版日 ページ情報 英文 100 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.71円で換算しております。
スコポラミンの世界市場:産業分析、市場規模、シェア、成長、動向、予測 Global Scopolamine Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
出版日: 2020年01月01日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界のスコポラミン市場を調査し、市場の概要、剤形・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 イントロダクション

  • 調査概要
  • 調査範囲
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 市場スナップショット

第3章 市場分析

  • イントロダクション
  • バリューチェーン分析
  • 成長要因
  • 阻害要因
  • 市場機会
  • ファイブフォース分析

第4章 スコポラミン市場の分析:剤形別

  • 錠剤
  • シロップ
  • 注射剤
  • パッチ
  • その他

第5章 スコポラミン市場の分析:流通チャネル別

  • 院内薬局
  • 小売薬局
  • オンライン薬局

第6章 スコポラミン市場の分析:地域別

  • 北米
    • 市場予測
    • 国別(米国、カナダ、その他)
  • 欧州
    • 市場予測
    • 国別(ドイツ、フランス、その他)
  • アジア太平洋地域
    • 市場予測
    • 国別(中国、日本、インド、その他)
  • ラテンアメリカ
    • 市場予測
    • 国別(ブラジル、その他)
  • 中東・アフリカ
    • 市場予測
    • 国別

第7章 競合情勢

  • 市場比較
  • パートナーシップ、提携、合意
  • 合併・買収
  • 新製品の上市
  • その他の動向

第8章 企業プロファイル

  • Alchem International
  • Alkaloids of Australia
  • Baxter International Inc.
  • Caleb Pharmaceuticals, Inc.
  • Centroflora-Cms
  • Fine Chemicals Corporation
  • GlaxoSmithKline plc
  • Myungmoon Pharma Co. LTD.
  • Novartis AG
  • Perrigo Company plc.
  • Phytex Australia
  • Tentative TOC
図表

LIST OF TABLES

  • Global Scopolamine Market Snapshot
  • Drivers of The Global Scopolamine Market Impact Analysis
  • Restraints of The Global Scopolamine Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Scopolamine Market Analysis by Dosage Form (USD MN)
  • Global Scopolamine Market Analysis in Tablet by Geography (USD MN)
  • Global Scopolamine Market Analysis in Syrup by Geography (USD MN)
  • Global Scopolamine Market Analysis in Injection by Geography (USD MN)
  • Global Scopolamine Market Analysis in Patch by Geography (USD MN)
  • Global Scopolamine Market Analysis in Others by Geography (USD MN)
  • Global Scopolamine Market Analysis by Distribution Channel (USD MN)
  • Global Scopolamine Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Scopolamine Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Scopolamine Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Scopolamine Market by Geography (USD MN)
  • North America Scopolamine Market Analysis by Dosage Form (USD MN)
  • North America Scopolamine Market Estimate by Distribution Channel (USD MN)
  • North America Scopolamine Market Estimate by Country (USD MN)
  • United State Scopolamine Market Analysis by Dosage Form (USD MN)
  • United State Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Rest of North America Scopolamine Market Analysis by Dosage Form (USD MN)
  • Rest of North America Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Europe Scopolamine Market Analysis by Dosage Form (USD MN)
  • Europe Scopolamine Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Scopolamine Market Analysis by Dosage Form (USD MN)
  • United Kingdom Scopolamine Market Estimate by Distribution Channel (USD MN)
  • France Scopolamine Market Analysis by Dosage Form (USD MN)
  • France Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Germany Scopolamine Market Analysis by Dosage Form (USD MN)
  • Germany Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Scopolamine Market Analysis by Dosage Form (USD MN)
  • Rest of Europe Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Scopolamine Market Analysis by Dosage Form (USD MN)
  • Asia Pacific Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Scopolamine Market Estimate by Country (USD MN)
  • China Scopolamine Market Analysis by Dosage Form (USD MN)
  • China Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Japan Scopolamine Market Analysis by Dosage Form (USD MN)
  • Japan Scopolamine Market Estimate by Distribution Channel (USD MN)
  • India Scopolamine Market Analysis by Dosage Form (USD MN)
  • India Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Scopolamine Market Analysis by Dosage Form (USD MN)
  • Rest of Asia Pacific Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Latin America Scopolamine Market Analysis by Dosage Form (USD MN)
  • Latin America Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Latin America Scopolamine Market Estimate by Country (USD MN)
  • Brazil Scopolamine Market Analysis by Dosage Form (USD MN)
  • Brazil Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Scopolamine Market Analysis by Dosage Form (USD MN)
  • Rest of Latin America Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Scopolamine Market Analysis by Dosage Form (USD MN)
  • Middle East & Africa Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Scopolamine Market Estimate by Country (USD MN)
  • Middle East Scopolamine Market Analysis by Dosage Form (USD MN)
  • Middle East Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Africa Scopolamine Market Analysis by Dosage Form (USD MN)
  • Africa Scopolamine Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of Scopolamine Report
  • Market Research Process
  • Market Research Methodology
  • Global Scopolamine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Dosage Form
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Scopolamine Market Analysis by Dosage Form (USD MN)
  • Global Scopolamine Market Analysis in Tablet by Geography (USD MN)
  • Global Scopolamine Market Analysis in Syrup by Geography (USD MN)
  • Global Scopolamine Market Analysis in Injection by Geography (USD MN)
  • Global Scopolamine Market Analysis in Patch by Geography (USD MN)
  • Global Scopolamine Market Analysis in Others by Geography (USD MN)
  • Global Scopolamine Market Analysis by Distribution Channel (USD MN)
  • Global Scopolamine Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Scopolamine Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Scopolamine Market Analysis in Online Pharmacies by Geography (USD MN)
  • Latin America Scopolamine Market by Revenue
  • Middle East & Africa Scopolamine Market by Revenue
  • Recent Development in Scopolamine Industry
  • Company Market Share Analysis, 2019

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次

Value Market Research's latest report on the Global Scopolamine Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global scopolamine market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global scopolamine market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global scopolamine market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global scopolamine market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global scopolamine market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global scopolamine market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global scopolamine market.

The market analysis involves a section exclusively to list the major players of the global scopolamine market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Scopolamine Market Report Segments the market as below:

By Dosage Form:

  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Scopolamine Market
  • 2.2. Global Scopolamine Market Snapshot

3 . SCOPOLAMINE - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Scopolamine Market
  • 3.3. Market Restraints of Scopolamine Market
  • 3.4. Opportunities of Scopolamine Market
  • 3.5. Trends of Scopolamine Market
  • 3.6. Porter's Five Force Analysis of Scopolamine Market
  • 3.7. Scopolamine Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Dosage Form
    • 3.7.2 Market Attractive Analysis by Distribution Channel
    • 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Scopolamine Value Chain Analysis
  • 4.2. Scopolamine Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Scopolamine Raw Material Manufactures List
    • 4.2.3. Price Trend of Scopolamine Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DOSAGE FORM

  • 5.1 Overview by Dosage Form
  • 5.2 Global Scopolamine Market Analysis by Dosage Form
  • 5.3 Market Analysis of Tablet by Regions
  • 5.4 Market Analysis of Syrup by Regions
  • 5.5 Market Analysis of Injection by Regions
  • 5.6 Market Analysis of Patch by Regions
  • 5.7 Market Analysis of Others by Regions

6 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 6.1 Overview by Distribution Channel
  • 6.2 Global Scopolamine Market Analysis by Distribution Channel
  • 6.3 Market Analysis of Hospital Pharmacies by Regions
  • 6.4 Market Analysis of Retail Pharmacies by Regions
  • 6.5 Market Analysis of Online Pharmacies by Regions

7 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview
    • 7.3.2. North America Scopolamine Market Estimate by Market Segment
    • 7.3.3. North America Scopolamine Market Estimate by Country
    • 7.3.4. United State
    • 7.3.5. Rest of North America
  • 7.4. Europe
    • 7.4.1. Overview
    • 7.4.2. Europe Scopolamine Market Estimate by Market Segment
    • 7.4.3. Europe Scopolamine Market Estimate by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7 Rest of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview
    • 7.5.2. Asia Pacific Scopolamine Market Estimate by Market Segment
    • 7.5.3. Asia Pacific Scopolamine Market Estimate by Country
    • 7.5.4. China
    • 7.5.5. Japan
    • 7.5.6. India
    • 7.5.7. Rest of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview
    • 7.6.2. Latin America Scopolamine Market Estimate by Market Segment
    • 7.6.3. Latin America Scopolamine Market Estimate by Country
    • 7.6.4. Brazil
    • 7.6.5. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview
    • 7.7.2. Middle East & Africa Scopolamine Market Estimate by Market Segment
    • 7.7.3. Middle East & Africa Scopolamine Market Estimate by Country
    • 7.7.4. Middle East
    • 7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE SCOPOLAMINE COMPANIES

  • 8.1. Scopolamine Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF SCOPOLAMINE INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Alchem International
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Alkaloids of Australia
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Baxter International Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Caleb Pharmaceuticals, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Centroflora-Cms
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Fine Chemicals Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. GlaxoSmithKline plc
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Myungmoon Pharma Co. LTD.
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Novartis AG
    • 9.11.1. Company Overview
    • 9.11.2. Financials
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Perrigo Company plc.
    • 9.12.1. Company Overview
    • 9.12.2. Financials
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Phytex Australia
    • 9.13.1. Company Overview
    • 9.13.2. Financials
    • 9.13.3. Products
    • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies